Green Cross
As of the edition of 20 October 2026, Green Cross runs 18 drugs, 1 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Green Cross was renamed.
- Green Cross Corporation: renamed
Drugs by status
| Status | Count |
|---|---|
| Marketed | 1 |
| Active | 2 |
| Went quiet | 13 |
| Status not established | 2 |
| Total | 18 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Idursulfase beta | none listed | 0 |
A route B row is one company at one target.
Where its trials are
- Infections: 19 trials led
- Lungs and airways: 8 trials led
- Digestive system: 7 trials led